MenFive

NmCV-5 · Serum Institute of India Pvt. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MenFive, covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate Vaccine

See pricing